Application of GC High Resolution Time-of-Flight Mass Spectrometry to Mouse Liver Metabolomic Analyses

Significance of the Topic

Gas chromatography high-resolution time-of-flight mass spectrometry (GC-HRT MS) combines sensitive chromatographic separation with accurate mass measurement, enabling comprehensive metabolomic profiling of liver tissue. Such analyses are critical for understanding biochemical alterations induced by environmental toxins like PCBs or lifestyle factors such as alcohol, and for identifying potential biomarkers of liver disease.

Objectives and Study Overview

This study applied LECO’s Pegasus® GC-HRT MS system to compare metabolite profiles in mouse livers from three dietary groups: high-fat diet alone, high-fat plus PCB exposure, and high-fat plus ethanol consumption. The aims were to:

• Identify metabolites showing significant abundance changes under PCB or ethanol treatment.
• Demonstrate the capability of high-resolution TOF MS for accurate identification via library matching and mass accuracy.

Methodology and Instrumentation

Metabolites were extracted from mouse liver, dried under nitrogen, and derivatized sequentially with methoxyamine in pyridine and MTBSTFA (1 % TBS). An internal standard mix was added prior to GC-HRT analysis. The system comprised an Agilent 7890 gas chromatograph coupled to a LECO Pegasus® high-resolution TOF MS equipped with a Restek Rxi-5Sil MS column (60 m × 0.25 mm i.d. × 0.25 µm film). Acquisition used accurate‐mass calibration to achieve fragment ion mass errors below 2 ppm.

Main Results and Discussion

Key findings included:

• Isoleucine and leucine bis-TBDMS derivatives were confidently identified (library match scores 830 and 740) with fragment masses within ±2 ppm of theoretical values. PCB exposure reduced both amino acids by ~20 % versus diet alone, whereas ethanol increased their levels 2–3-fold.
• Trans-13-octadecenoic acid t-butylmethylsilyl ester was matched with a spectral score >770 and fragment masses accurate to <2 ppm. PCB treatment elevated its abundance ~3-fold, and ethanol treatment elevated it ~8-fold relative to controls.

Benefits and Practical Applications

This workflow provides:

• High selectivity for isomeric metabolites via accurate-mass extracted ion chromatograms.
• Robust identification combining library matching and high mass accuracy for both molecular and fragment ions.
• Quantitative comparison of treatment effects in complex tissue matrices, supporting biomarker discovery for liver diseases.

Future Trends and Potential Applications

Advances may include integration with multi-omics platforms, automated data processing for large-scale studies, and expansion to human clinical samples. Combining GC-HRT MS with isotope-labeling strategies and advanced chemometrics could further enhance sensitivity to subtle metabolic shifts in disease progression and treatment response.

Conclusion

The Pegasus® GC-HRT MS system effectively characterized metabolic perturbations in mouse liver induced by PCBs and ethanol under high-fat dietary conditions. Accurate mass measurement and reliable library matching enabled clear differentiation of isobaric species and quantification of treatment-dependent changes, demonstrating the platform’s value for liver disease metabolomics.

References

1. Wapner J. Scientific American, October 21, 2010.
2. Loftus N, Barnes A, Ashton S, et al. J Proteome Res. 2011;10(2):705–713.